The General Inspection of Health Activities (IGAS) has concluded that access to the neuropediatric consultation of the Portuguese-Brazilian twins treated at Santa Maria Hospital with a drug worth millions of euros was illegal.
In the conclusions of the inspection report, released today, the IGAS states that “the legal requirements for the two children’s access to the neuropediatric consultation were not met”, since the appointment did not comply with the ordinance that regulates users’ access to the National Health Service,
The IGAS also concluded that the health care provided to the children took place “without there having been any facts worthy of any kind of censure”.
The case of the two twins living in Brazil who acquired Portuguese nationality and received the drug Zolgensma in Portugal in 2020, at a total cost of four million euros, was reported by TVI in November and is still being investigated by the Attorney General’s Office (PGR).
